ARCHIVES

DCE Board Approves Concepts For New Chemoprevention Groups, Retroviral Vaccine Research, Biochemical Markers, Feline Virus Studies

This article is from The Cancer Letter archive.

Vol. 11 No. 11 | March 15, 1985

Download PDF Visit The Full Archive

Related Articles

In Brief: CCIRC Recommends Central Oncology Group For Phasing Out; Rogers Backs Pay Raise

March 5, 1976

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

DCPC BSC Committee Endorses Three Research Concepts

April 17, 1987

In Brief: NCCS to hold Candlelight Vigil Sept. 25; Moffit Wins Chemistry-Biology Grants

September 17, 1999

Underpowered Study Of Evacet Dashes Approval Hopes

September 24, 1999

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005